Login / Signup

Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy.

Jessica L WardEfrem Z KussinMelissa A TropfSandra P TouTeresa C DeFrancescoBruce W Keene
Published in: Journal of veterinary internal medicine (2020)
Pimobendan is well tolerated in cats with cardiomyopathy and CHF, regardless of the presence of OTO.
Keyphrases
  • heart failure
  • open label
  • cross sectional
  • hypertrophic cardiomyopathy
  • randomized controlled trial
  • clinical trial
  • left ventricular
  • placebo controlled